36745687|t|Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.
36745687|a|Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder caused by progressive loss of motor neurons and there is currently no effective therapy. Cytoplasmic mislocalization and aggregation of TAR DNA-binding protein 43 kDa (TDP-43) within the CNS is a pathological hallmark in sporadic ALS and prion-like propagation of pathogenic TDP-43 is thought to be implicated in disease progression. However, cell-to-cell transmission of pathogenic TDP-43 in the human CNS has not been confirmed experimentally. Here we used induced pluripotent stem cells (iPSCs)-derived cerebral organoids as recipient CNS tissue model that are anatomically relevant human brain. We injected postmortem spinal cord protein extracts individually from three non-ALS or five sporadic ALS patients containing pathogenic TDP-43 into the cerebral organoids to validate the templated propagation and spreading of TDP-43 pathology in human CNS tissue. We first demonstrated that the administration of spinal cord extracts from an ALS patient induced the formation of TDP-43 pathology that progressively spread in a time-dependent manner in cerebral organoids, suggesting that pathogenic TDP-43 from ALS functioned as seeds and propagated cell-to-cell to form de novo TDP-43 pathology. We also reported that the administration of ALS patient-derived protein extracts caused astrocyte proliferation to form astrogliosis in cerebral organoids, reproducing the pathological feature seen in ALS. Moreover, we showed pathogenic TDP-43 induced cellular apoptosis and that TDP-43 pathology correlated with genomic damage due to DNA double-strand breaks. Thus, our results provide evidence that patient-derived pathogenic TDP-43 can mimic the prion-like propagation of TDP-43 pathology in human CNS tissue. Our findings indicate that our assays with human cerebral organoids that replicate ALS pathophysiology have a promising strategy for creating readouts that could be used in future drug discovery efforts against ALS.
36745687	24	53	amyotrophic lateral sclerosis	Disease	MESH:D000690
36745687	61	67	TDP-43	Gene	23435
36745687	101	130	Amyotrophic lateral sclerosis	Disease	MESH:D000690
36745687	132	135	ALS	Disease	MESH:D000690
36745687	148	174	neurodegenerative disorder	Disease	MESH:D019636
36745687	311	341	TAR DNA-binding protein 43 kDa	Gene	23435
36745687	343	349	TDP-43	Gene	23435
36745687	405	408	ALS	Disease	MESH:D000690
36745687	450	456	TDP-43	Gene	23435
36745687	558	564	TDP-43	Gene	23435
36745687	572	577	human	Species	9606
36745687	761	766	human	Species	9606
36745687	854	857	ALS	Disease	MESH:D000690
36745687	875	878	ALS	Disease	MESH:D000690
36745687	879	887	patients	Species	9606
36745687	910	916	TDP-43	Gene	23435
36745687	1000	1006	TDP-43	Gene	23435
36745687	1020	1025	human	Species	9606
36745687	1116	1119	ALS	Disease	MESH:D000690
36745687	1120	1127	patient	Species	9606
36745687	1153	1159	TDP-43	Gene	23435
36745687	1273	1279	TDP-43	Gene	23435
36745687	1285	1288	ALS	Disease	MESH:D000690
36745687	1353	1359	TDP-43	Gene	23435
36745687	1415	1418	ALS	Disease	MESH:D000690
36745687	1419	1426	patient	Species	9606
36745687	1491	1503	astrogliosis	Disease	MESH:D005911
36745687	1572	1575	ALS	Disease	MESH:D000690
36745687	1608	1614	TDP-43	Gene	23435
36745687	1651	1657	TDP-43	Gene	23435
36745687	1772	1779	patient	Species	9606
36745687	1799	1805	TDP-43	Gene	23435
36745687	1846	1852	TDP-43	Gene	23435
36745687	1866	1871	human	Species	9606
36745687	1927	1932	human	Species	9606
36745687	1967	1970	ALS	Disease	MESH:D000690
36745687	2095	2098	ALS	Disease	MESH:D000690
36745687	Positive_Correlation	MESH:D000690	23435

